Population-Based Analysis of Differences in Gastric Cancer Incidence Among Races and Ethnicities in Individuals Age 50 Years and Older
- PMID: 32771406
- PMCID: PMC7680373
- DOI: 10.1053/j.gastro.2020.07.049
Population-Based Analysis of Differences in Gastric Cancer Incidence Among Races and Ethnicities in Individuals Age 50 Years and Older
Erratum in
-
Correction.Gastroenterology. 2021 Apr;160(5):1904. doi: 10.1053/j.gastro.2021.03.035. Epub 2021 Mar 26. Gastroenterology. 2021. PMID: 33775631 No abstract available.
Abstract
Background & aims: There are racial and ethnic differences in the incidence of gastric adenocarcinoma worldwide and in the US. Based on a decision analysis, screening for noncardia gastric adenocarcinoma might be cost-effective for non-White individuals 50 years or older. However, a lack of precise, contemporary information on gastric adenocarcinoma incidence in specific anatomic sites for this age group has impeded prevention and early detection programs in the US. We aimed to estimate the differences in gastric adenocarcinoma incidence in specific anatomic sites among races and ethnicities in individuals 50 years or older.
Methods: We analyzed California Cancer Registry data from 2011 through 2015 to estimate incidences of gastric adenocarcinoma in specific anatomic sites for non-Hispanic White (NHW), non-Hispanic Black, Hispanic, and the 7 largest Asian American populations. We calculated the differential incidence between non-White groups and NHW using incidence rate ratios and 95% confidence intervals (CIs).
Results: Compared with NHW subjects, all non-White groups had significantly higher incidences of noncardia gastric adenocarcinoma; the incidence was highest among Korean American men 50 years and older (70 cases per 100,000). Compared with NHW subjects 50 years and older, the risk of noncardia gastric adenocarcinoma was 1.8-fold (95% CI, 1.37-2.31) to 7.3-fold (95% CI, 5.73-9.19) higher in most non-White groups and 12.0-fold (95% CI, 9.96-14.6) to 14.5-fold (95% CI, 12.5-16.9) higher among Korean American men and women 50 years and older, respectively. Compared with NHW men 50 years and older, all non-White men, except Japanese and Korean American men, had a significantly lower risk of cardia gastric adenocarcinoma.
Conclusions: We identified several-fold differences in incidences of gastric adenocarcinoma in specific anatomic sites among racial and ethnic groups, with significant age and sex differences. These findings can be used to develop targeted risk reduction programs for gastric adenocarcinoma.
Keywords: Epidemiology; Healthcare Disparity; Helicobacter pylori; Stomach Cancer.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424. - PubMed
-
- Stomach Cancer – Cancer Stat Facts. https://seer.cancer.gov/statfacts/html/stomach.html (accessed Feb 12, 2019).
-
- Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut 2015; 64: 1881–8. - PubMed
Publication types
MeSH terms
Grants and funding
- K12 HS026395/HS/AHRQ HHS/United States
- HHSN261201800032C/CA/NCI NIH HHS/United States
- HHSN261201800009C/CA/NCI NIH HHS/United States
- U54 CA132384/CA/NCI NIH HHS/United States
- NU58DP006344/DP/NCCDPHP CDC HHS/United States
- R01 CA077955/CA/NCI NIH HHS/United States
- P30 DK058404/DK/NIDDK NIH HHS/United States
- HHSN261201800015I/CA/NCI NIH HHS/United States
- R37 CA222866/CA/NCI NIH HHS/United States
- P01 CA116087/CA/NCI NIH HHS/United States
- UG3 CA233314/CA/NCI NIH HHS/United States
- HHSN261201800032I/CA/NCI NIH HHS/United States
- IK2 CX002027/CX/CSRD VA/United States
- HHSN261201800009I/CA/NCI NIH HHS/United States
- P30 CA023100/CA/NCI NIH HHS/United States
- U54 CA132379/CA/NCI NIH HHS/United States
- R01 DK058587/DK/NIDDK NIH HHS/United States
- HHSN261201800015C/CA/NCI NIH HHS/United States
